The experiments revealed a reduced expression of SRSF1 and SRSF2 in pancreatic, kidney, colorectal, and stomach cancer cell lines as well as in cancer tissues — SRSF2 was downregulated in stomach tumors, while SRSF1 was reduced in all types of tested tumors [39]. Here, SRSF2 is linked to gastric cancer.